In June 2025, the MHRA published updated contraception guidance for women taking GLP-1 medications, advising that women taking Mounjaro should use a non-oral form of contraception (such as a coil, implant, or patch) or add a barrier method for at least four weeks after starting treatment and after every dose increase
That way, youre not just taking a medication, youre making a thoughtful, supported decision
PlexusDx compounded semaglutide allows flexible treatment windows so you can assess your response and adjust your plan based on actual outcomes rather than guesses
Each ESTHER FORMULA product is grounded in medical expertise and met quality standards from ingredient sourcing to manufacturing during its development
If accurate creatinine-based testing is needed, stopping creatine for 30 days before bloodwork allows creatinine to normalize